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Background: During its persistence in cystic fibrosis (CF) airways, P. aeruginosa
develops a series of phenotypic changes by the accumulation of pathoadaptive
mutations. A better understanding of the role of these mutations in the adaptive process,
with particular reference to the development of multidrug resistance (MDR), is essential
for future development of novel therapeutic approaches, including the identification of
new drug targets and the implementation of more efficient antibiotic therapy. Although
several whole-genome sequencing studies on P. aeruginosa CF lineages have been
published, the evolutionary trajectories in relation to the development of antimicrobial
resistance remain mostly unexplored to date. In this study, we monitored the adaptive
changes of P. aeruginosa during its microevolution in the CF airways to provide an
innovative, genome-wide picture of mutations and persistent phenotypes and to point
out potential novel mechanisms allowing survival in CF patients under antibiotic therapy.
Results: We obtained whole genome sequences of 40 P. aeruginosa clinical CF strains
isolated at Trentino Regional Support CF Centre (Rovereto, Italy) from a single CF patient
over an 8-year period (2007–2014). Genotypic analysis of the P. aeruginosa isolates
revealed a clonal population dominated by the Sequence Type 390 and three closely
related variants, indicating that all members of the population likely belong to the same
clonal lineage and evolved from a common ancestor. While the majority of early isolates
were susceptible to most antibiotics tested, over time resistant phenotypes increased
in the persistent population. Genomic analyses of the population indicated a correlation
between the evolution of antibiotic resistance profiles and phylogenetic relationships,
and a number of putative pathoadaptive variations were identified.
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Conclusion: This study provides valuable insights into the within-host adaptation and
microevolution of P. aeruginosa in the CF lung and revealed the emergence of an MDR
phenotype over time, which could not be comprehensively explained by the variations
found in known resistance genes. Further investigations on uncharacterized variations
disclosed in this study should help to increase our understanding of the development of
MDR phenotype and the poor outcome of antibiotic therapies in many CF patients.
Keywords: Pseudomonas aeruginosa, persistence, cystic fibrosis, genome evolution, antibiotic resistance
INTRODUCTION
Pseudomonas aeruginosa is the most prevalent of all potential
opportunistic nosocomial pathogens causing pulmonary and
bloodstream infection with high mortality rates of up to 50%
(Osmon et al., 2004). Cystic fibrosis (CF) patients infected with
P. aeruginosa are exposed to increased morbidity and mortality
(Lyczak et al., 2000; Chmiel and Davis, 2003). Progressive
airway infection in CF subjects typically begins with recurrent
P. aeruginosa infections that are often cleared by antibiotics
and subsequently replaced by other strains that can establish
permanent chronic infections in the respiratory tract (Folkesson
et al., 2012). Long-term colonization of the CF airway is sustained
by P. aeruginosa lineages which are clonal to the initially acquired
strain (Bragonzi et al., 2009) and can persist in the airway of a
patient for years and even decades (Jelsbak et al., 2007; Cramer
et al., 2010).
Convergence of phenotypic changes among clinical isolates
with a high level of initial phenotypic diversity within a single
patient and between multiple strains from the same sample
has been previously reported (Workentine et al., 2013; Jeukens
et al., 2014; Caballero et al., 2015; Darch et al., 2015; Williams
et al., 2015). Most common phenotypic changes during persistent
infections include the conversion to a mucoid phenotype, loss
of pigmentation, motility, secreted and cell-associated virulence
factors, emergence of small colony variants (SCVs), use of
alternative metabolic pathways, increased mutation rate, and the
acquisition of multidrug resistance (Hogardt and Heesemann,
2010; Folkesson et al., 2012; Sousa and Pereira, 2014; Sommer
et al., 2016).
A set of 24 genes in three different P. aeruginosa lineages
have been reported to have undergone similar changes in
their respective gene expression profiles (Huse et al., 2010),
confirming the occurrence of convergent evolution in CF, in
which different lineages tend to develop the same adaptive
traits independently, due to the stressful CF lung environment.
In another study (Marvig et al., 2015), the genomes of 474
longitudinal P. aeruginosa isolates collected from 34 CF patients
for an average 5-year period were sequenced; they found 52
common genes mutated in all different lineages confirming that
P. aeruginosa strains of various genetic backgrounds adapt to the
CF airway following a convergent evolutive process. On the other
hand, a high level of phenotypic diversity within a single patient
and also between multiple isolates of the same sputum sample
has also been reported (Huse et al., 2010; Folkesson et al., 2012).
Although most P. aeruginosa infections have a clonal origin,
persistent infections are characterized by an adaptive radiation
process diversifying the initial clone in various morphotypes
(Hogardt and Heesemann, 2010), and leading to the occurrence
of subpopulations within the same host (Cullen and McClean,
2015).
As mentioned above, during chronic infection, the bacterium
may develop a multidrug resistance (MDR) phenotype by the
accumulation of pathoadaptive mutations or the acquisition of
mobile elements by horizontal gene transfer (Breidenstein et al.,
2011). Estimates indicate that 25–45% of adult CF patients are
chronically infected with MDR P. aeruginosa within their airway
(Lechtzin et al., 2006). Whole-genome sequencing (WGS) can
help to point out potential molecular mechanisms of antibiotic
resistance and has already proved to be able to successfully predict
antimicrobial susceptibility in several pathogens (Stoesser et al.,
2013; Zankari et al., 2013). Nevertheless, despite the availability
of>2,000 P. aeruginosa genomes, knowledge on the evolution of
genomic features associated with persistence and antimicrobial
resistance is still incomplete.
In the present work, we sequenced the whole genome of 40
P. aeruginosa isolates from a single CF patient spanning an 8-
year period. We analyzed the population in terms of clonality
of the isolates, phylogenetic relationships, polymorphisms in
the core genome and variations in the accessory genome.
We also characterized the antibiotic resistance profile of the
isolates and checked for mutations and variations in antibiotic
resistance genes among the population. A better understanding
of the evolutionary dynamics occurring during chronic airway
infections in CF patients and of the genetic adaptation of strains
to the CF lung environment should provide clues for preventive
measures or novel therapies to control CF infections in the future.
MATERIALS AND METHODS
Bacterial Strains
Pseudomonas aeruginosa strains were isolated from the sputum
of a single adult male CF patient, aged 24 at the beginning of
sampling. The patient carries the heterozygous CFTR mutations
1F508 and G542X, and he was treated at the Trentino Regional
Support CF Centre and the Operative Unit of Clinical Pathology
(Hospital of Rovereto, Italy) (Supplementary Figure S1 and
Supplementary Table S1).
A total of 40 P. aeruginosa strains were isolated over an 8-
year period (2007–2014). To evaluate both the suitability of the
material from the lower respiratory tract of the patient (sputum)
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and the putative pathogens present, a microscopic examination
was carried out using Bartlett’s criteria. Sputum samples were
fluidized with the addition of dithiothreitol and plated on blood
agar and MacConkey agar plates. Pseudomonas aeruginosa was
identified using the API ID32GN kit (bioMérieux, Bagno a Ripoli,
Italy). Strains from the same sputum samples showing a different
colony morphology were collected and characterized separately
(Bianconi et al., 2016; D’Arcangelo, 2017).
Antimicrobial Susceptibility Testing
MIC values for all 40 strains were determined by reference broth
microdilution using TREK Sensititre custom panel ITGNEGF
(Thermo-Fisher, Waltham, MA, United States). The following
12 antibiotics belonging to nine different classes were tested:
amikacin, gentamicin, imipenem, meropenem, doripenem,
ceftazidime, cefepime, ciprofloxacin, levofloxacin, fosfomycin,
colistin, and a combination of piperacillin/tazobactam.
Mucoid Phenotype
Isolates were inoculated on Pseudomonas Isolation Agar (BD,
Franklin Lakes, NJ, United States) for 48–72 h at 37◦C. Strains
producing alginate were considered positive (Bragonzi et al.,
2006).
Biofilm Formation Assay
Biofilm formation was assessed by the crystal violet staining
assay with minor modifications (O’Toole, 2011). Briefly, pellets
of overnight cultures were collected by centrifugation and
re-suspended in M63 liquid medium (Amresco, Solon, OH,
United States) to a final OD600 of 0.005 and aliquoted in
a 96-well U-bottom microtiter plate (Costar, Washington,
DC, United States). After 24 h of static incubation at 37◦C,
supernatants were removed, and OD600 was measured. Cells
attached to the microtiter wells were washed and stained with
an aqueous solution of 0.1% crystal violet. Cells were washed
and resuspended in 30% acetic acid. OD550 of resuspended
biofilm was determined and normalized to the OD600 of the
corresponding planktonic cells. The assay was repeated at least
three times per isolate.
DNA Extraction, Genome Sequencing,
and Assembly
The genome sequences of the isolates were previously published
under accession numbers MAUO00000000 – MBMR00000000
(Supplementary Table S2) (Bianconi et al., 2016).
Genomic DNA was extracted from overnight cultures in LB
Broth (Oxoid, Sigma-Aldrich, Darmstadt, Germany) at 37◦C
with continuous shaking, using the DNeasy Blood and Tissue
Kit (Qiagen, Hilden, Germany) following the manufacturer’s
instructions for Gram-negative bacteria. Sequencing libraries
were prepared using the Nextera XT DNA Library Preparation
Kit (Illumina, San Diego, CA, United States) with default
settings and sequenced on the Illumina MiSeq platform. De novo
assembly of draft genomes was carried out using SPAdes version
3.1.0 (Bankevich et al., 2012), with the following options: –
careful on and k-mer sizes set as 21,33,55,77,99,127. To further
improve the quality of the assemblies, raw reads were mapped on
the contigs using Bowtie2 (Langmead and Salzberg, 2012), and
contigs with less than three reads mapping and/or with coverage
below one were removed. Draft genomes were reordered using
Mauve (Darling et al., 2010) with P. aeruginosa DK2 strain
sequence used as a reference.
Genotyping, Genome Annotation,
Pangenome, and SNPs Analysis
MLST 1.8 (Larsen et al., 2012) was used for genotyping
of the population from de novo assembled genomes. An
eBURST analysis (eBURST V3, Feil et al., 2004) was carried
out to estimate the relatedness of Sequence Types (STs).
In silico determination of the O-antigen was performed using
the Pseudomonas aeruginosa serotypes (PAst) script1. Genome
annotation was performed with Prokka automatic annotation
tool v1.11 (Seemann, 2014), and analysis of the core and
accessory genomes was carried out using Roary with default
settings (Page et al., 2015). An accessory genome presence
matrix was created from the standard Roary output file and
isolates’ values were plotted ordered by isolation date with
the ggpubr package inside R/Bioconductor environment2. To
assess the number of gene acquisition/loss events, all acquired
genes (n = 542) were pooled to a gene dataset composed by
the accessory genes of the first isolated strains TNCF_3 and
TNCF_4M (n = 624); each isolate was compared with these two
datasets. The barplot was generated using the ggpubr package as
above.
SNPs were identified using Snippy3 (Seemann, 2015). This
software infers polymorphisms at the nucleotide level by aligning
the unassembled reads to a reference genome (in this study
we used P. aeruginosa DK2) and it calls the software SnpEff
to annotate and predict the effect of each mutation (Cingolani
et al., 2012), dividing them into low (e.g., synonym mutations),
moderate (e.g., inframe deletion/insertion) and high (e.g., stop
gained).
Plasmids and Genomic Islands
Prediction
To detect the presence of plasmids from NGS data, the software
PlasmidSeeker was used (Roosaare et al., 2018). The algorithm
allows the identification of plasmids using the information of
plasmid k-mer coverage, which is expected to be higher than
that of the genome. For each set of reads we used the respective
assembled genome. In addition, we performed two separate
analyses using the reference genomes of PAO1 and PA14. The
plasmids k-mer database consists of >8,500 known plasmids
from several species, 14 of which are specific for P. aeruginosa.
The occurrence and distribution of genomic islands (GIs)
were inferred using IslandViewer4 (Bertelli et al., 2017).
Prokka output files in GenBank format were uploaded to
the IslandViewer web server. To obtain a set of homologous
1https://github.com/Sandramses/PAst
2https://www.rdocumentation.org/packages/ggpubr
3https://github.com/tseemann/snippy
Frontiers in Microbiology | www.frontiersin.org 3 January 2019 | Volume 9 | Article 3242
fmicb-09-03242 January 7, 2019 Time: 16:57 # 4
Bianconi et al. Pseudomonas aeruginosa Microevolution Longitudinal Study
protein clusters (PCs), the proteins found by IslandViewer
were clustered using CD-HIT (Fu et al., 2012), with both
coverage and identity percentage set at 95%. A genome map
of the distribution of the islands in each isolate was drawn
using the package genoplotR. Also, PCs were mapped against
a custom dataset of 23 previously characterized GIs using
tblastn. Ubiquitous PCs that could not be assigned to any of
the known GIs were searched on the whole non-redundant
NCBI protein database using blastp, restricting the analysis to
P. aeruginosa sequences. To determine the occurrence of a
phylogenetic signal in the distribution of non-ubiquitous PCs, a
phylo.d analysis (R-package caper) (Fritz and Purvis, 2010) was
performed.
Type II Toxin–Antitoxin (TA) Systems
Detection
Putative type II toxin–antitoxin (TA) loci were identified by using
the online server TAfinder4 (Shao et al., 2011; Xie et al., 2018).
Newly assembled genomes were previously annotated with the
online tool CDSeasy5. Output GenBank files were uploaded in
TAfinder and analyzed using default parameters.
Phylogenetic Tree Construction
A rooted phylogenetic tree, based on the distribution of SNPs
in the core genome, was then obtained using BEAST V1.8.3
(Drummond et al., 2012). A Markov Chain Monte Carlo chain
was run for 9 × 108 steps using the uncorrelated relaxed clock
model (Drummond et al., 2006) with lognormal distribution
and gtr substitution model with gamma-distributed rates, four
categories, shape parameter α. After a burn-in of 4 × 108 steps,
trees were recorded every 10.000 steps, and the consensus tree
was determined using TreeAnnotator. To evaluate the amount
of recombining sites, the phylogenetic tree, together with the
alignment of core genes obtained by Roary, were analyzed using
clonalframeML (Didelot and Wilson, 2015).
Detection of Phylogenetic Signal and
Molecular Evolution Analysis
The phylo.d function within the R package was used to measure
the strength of phylogenetic signal in binary traits6. Two
simulated null models were used to standardize the phylogenetic
signal: phylogenetic randomness and Brownian threshold.
Genes with multiple SNPs were initially considered to
be under non-neutral selection. This statement was further
verified with the following procedure: (i) the alignment of
each homologous gene with reference sequence was exported
in FASTA format; (ii) the dN/dS ratio was determined using
codeml as implemented in PAML package (Yang, 2007) and
the likelihood of four different models (two neutral or nearly
neutral, M1a and M7, respectively, and the two corresponding
positive selection models M2a and M8) was determined; (iii) the
likelihood ratio test, using as null model the neutral one, was
4http://202.120.12.133/TAfinder/index.php
5http://202.120.12.133/STEP/STEP_CDSeasy.php
6https://www.rdocumentation.org/packages/caper/versions/0.5.2/topics/phylo.d
FIGURE 1 | eBURST analysis of the sequence types found in the
P. aeruginosa population. The five variants (ST1863, ST1864, ST1865,
ST1921, ST2301, and ST1923) differed from ST390 at a single locus. Variants
ST1863, ST1864, ST1923 were discovered in the present study.
performed to determine which model better fitted the observed
data (Anisimova and Gascuel, 2006; Yang, 2006). The procedure
was implemented in a conservative way to detect non-neutral
selection in highly similar sequences, using as null model the
neutral one.
RESULTS
Whole-Genome Sequencing and in silico
MLST Genotyping
In this study, we sequenced 40 P. aeruginosa isolates from a CF
patient over an 8-year period. The average number of contigs per
genome was 101 (range 53–356). Mean size of the draft genomes
was 6.6 Mb (range 6.545–6.653). Mean G+C content was 66,28%
and the genomes encoded for an average of 6,151 putative ORFs.
Details of the genomes obtained are provided in Table 1 and
preliminarily described in Bianconi et al. (2016).
In silico MLST analysis revealed a population dominated by
a previously characterized Sequence Type (ST390, 30 isolates),
and three new ST variants (Figure 1): ST1864 (six isolates:
TNCF_16, TNCF_85, TNCF_88M, TNCF_101, TNCF_133_1,
TNCF_151M), ST1923 (three isolates: TNCF_155_1, TNCF_165,
TNCF_176) and ST1863 (one isolate: TNCF_69). ST390
(allelic profile: acs39-aro5-gua1-mut3-nuo4-pps46-trp56) was
previously detected in six isolates: in a sputum sample from a CF
patient (Canada, in 2004), in an environmental sample (France,
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TABLE 1 | Genomic features and statistics of the 40 P. aeruginosa CF isolates.
Values Assembly statistics Annotation statistics
# Read pairs Avg.cov # Contigs N50 GC% TOT length CDS tRNA
Minimum 156677 4 53 31 66.27 6545 6052 53
Average 581968 22 101 180 66.28 6633 6151.4 59
Median 517366 21 86 177 66.28 6635 6151.5 60
Maximum 1226553 42 356 378 66.36 6653 6219 66
FIGURE 2 | Rooted phylogeny of the P. aeruginosa population. The tree was built on core genome SNPs obtained using BEAST V1.8 with 10 independent runs of
109 steps using the relaxed clock model. Different strains isolated from the same sputum sample share the same isolation date. The right panel reports the date of
sampling and the Sequence Type of each isolate.
in 2009), and in four unspecified isolates7. The novel variants
were deposited in the PubMLST database8.
7https://pubmlst.org/bigsdb?db=pubmlst_paeruginosa_isolates&page=profiles
8https://pubmlst.org/
Phylogenetic Analyses
To reconstruct the evolutionary history of the lineage and to
examine the relationships between the isolates we analyzed the
distribution of SNPs in the core genome using BEAST. The tree
topology (Figure 2) indicates that the population is composed
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FIGURE 3 | Core and accessory genome proportions in the P. aeruginosa
population. Genomic portions present in 38 or 39 isolates out of 40 (softcore)
were considered as core genes in the text due to the draft assembly of the
genomes.
of two main clusters separated by a sizeable basal split: the first
one comprised nearly all the early isolates (13 out of a total of 17
isolates sampled between 2007 and 2008), whereas the majority
of the late isolates branched within the second cluster (17 out of
a total of 23 isolates sampled between 2010 and 2014). The most
recent common ancestor of the former clade is dated by BEAST
in 1988± 19.9 years, and in 1992± 14.8 years for the latter, while
the date of the divergence of the two clades was estimated to be
1979± 21 years. Such high standard deviations thus do not allow
to infer divergence times in the population. Regardless of their
placement in the phylogenetic tree, all late isolates had longer
branches compared to early ones, indicating a more substantial
genomic diversity of the formers and/or a different evolutionary
rate between the two groups of isolates. The six ST1864 isolates
appear to be polyphyletic and fall in the cluster with ST390 early
isolates, while the three ST1923 isolates and the ST1863 one
group in the cluster with the late ST390 isolates sampled between
2010 and 2014.
Excluding homoplasic sites with ClonalFrameML
(Supplementary Figure S2), a number of branches collapsed,
suggesting that most of the variability within the population is
due to horizontal transfer and/or convergent evolution.
Core and Accessory Genome Analyses
Previous studies have shown that the genomes of P. aeruginosa
isolates are usually highly conserved (Klockgether et al., 2011,
2013). Analyses of the core and accessory genome of the
population confirmed the high homogeneity of these strains
revealed by in silico MLST. The pan-genome of the population
comprised 7,035 genes, with nearly 85% of the genes shared
between all the isolates (5,972 genes). Among these, 5608 were
core genes present in 39–40 isolates, and 364 were soft core
genes found in at least 38 isolates (Figure 3). A total of 1,166
genes (16%) belonged to the accessory genome (Figure 4A).
Among these, 624 were shell genes present in the initial isolates
(TNCF_3 or TNCF_4M), while 542 were acquired in the course
of time (2,766 days). Among the latter genes, 320 were found to
be present only in one isolate (TNCF_6). The average number
of accessory genes per genome was 500, with TNCF_12 being
the isolate with the smallest accessory genome (394 genes) and
TNCF_6 the one with the largest one (523 genes), consistent with
the greater length of its genome. In order to get insight into
the dynamics of acquisition/loss of accessory genes, we assessed
for each isolate the number of genes belonging to each class. As
shown in Figure 4B, the general trend in the microevolution
of this population leans toward a higher number of gene loss
events compared to gene acquisition. The accessory genomes
mapped on the phylogenetic tree (Supplementary Figure S3)
showed an extensive collapse at the root, and the presence of three
major lineages: one includes 31 out of 40 isolates (the bulk of
the population); a second lineage comprises isolates TNCF_23,
TNCF_10 and TNCF_42M, which formed a monophyletic group
also in the SNP-based tree; the third lineage includes TNCF_16,
TNCF_7M, TNCF_4M, TNCF_10M, TNCF_32M, TNCF_151M.
TNCF_6 also resulted in being the strain with the most diverse
accessory genome, in agreement with its high number of unique
regions.
Clustering of isolates based on the composition of the
accessory genome (Supplementary Figure S4) revealed a
group of 11 highly similar genomes comprising both early
and late isolates, eight belonging to the dominant ST390
type (TNCF_10, TNCF_13, TNCF_23, TNCF_23M, TNCF_32,
TNCF_42, TNCF_42M, TNCF_49M) and three belonging to
the derivate ST1864 (TNCF_16, TNCF_88M and TNCF_133_1).
Accordingly, the number of accessory genes in each genome of
this cluster was remarkably homogeneous, ranging from 488 to
511 genes in TNCF_16 and TNCF_10, respectively.
Identification of Plasmids and Genomic
Islands
The analyses performed using PAO1, PA14 and each assembled
genome as reference detected only one plasmid, belonging to the
pKLC102 family, which was ubiquitous in the population with
the exception of isolate TNCF_12.
The distribution of PCs was strongly skewed toward the
two extremes, i.e., most of the PCs were either ubiquitous or
isolate-specific; 87 PCs, belonging to six GIs, were ubiquitous
in the population (Figure 5). The tblastn analysis performed
on our custom dataset of known GIs detected four PCs (with
identity > 80% and e-value < 4.7 e80) putatively belonging to
the island LESGI-1 (Winstanley et al., 2009), two PCs (id > 85%,
e-value < 1.7 e46) were assigned to LESGI-3 (Winstanley et al.,
2009), and three PCs (id> 90%, e-value< 5.3 e80) were assigned
to the island PAGI-2 (Klockgether et al., 2007).
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FIGURE 4 | Analyses of the accessory genome. (A) Distribution of accessory genes in the population. Each row represents an isolate and each column represents a
gene (gene labels not shown). The gradient represents the time (in days) starting from the isolation date of the first two strains (TNCF_3 and TNCF_4M). (B) Loss or
acquisition of accessory genes in the population. Barplots represent the acquired/lost genes (in red and blue, respectively) for each isolate in comparison with the
two first isolates TNCF_3 and TNCF_4M.
FIGURE 5 | Genomic map showing the position of each genomic island on each genome. Homologous regions are highlighted in green.
Twenty-one ubiquitous PCs, belonging to the three yet
unidentified GIs found in the collection, were mapped against
the non-redundant NCBI database restricting the search to
P. aeruginosa. Most PCs matched with hypothetical proteins,
and only six PCs matched with the following annotated proteins:
YqaJ-like viral recombinase domain cl09232 (WP_031641785),
recombination protein RecT (WP_019682741), resolvase
(EJY58266), serine recombinase (WP_070330427), DNA
ligase [NAD(+)] LigA (WP_003114675), N-acetyltransferase
(WP_003096122).
Type II Toxin–Antitoxin Systems
Most genes belonging to the TA systems were found to be
ubiquitous in the population. Non-ubiquitous TA genes belonged
Frontiers in Microbiology | www.frontiersin.org 7 January 2019 | Volume 9 | Article 3242
fmicb-09-03242 January 7, 2019 Time: 16:57 # 8
Bianconi et al. Pseudomonas aeruginosa Microevolution Longitudinal Study
to domains COG1733 (found in 37 isolates), pfam13420 (38
isolates), pfam00392 (39) and PRK10151 (which was found only
in one isolate, TNCF_7M). TA families Abr-like (COG4456
domain), vapC (cd009981 domain) and RHH-like were present
in nearly all isolates (39). Genes belonging to the Xre-like family
were the most abundant with at least four genes in each genome
(Supplementary Figure S5).
The total number of TA genes found in the isolates ranged
from 30 (in TNCF_12) to 36 (in TNCF_101), and the average
number of genes was 34. There was no difference among early
and late isolates in terms of presence or abundance of TA families
or domains, (Supplementary Figure S6).
Variants and SNPs Analysis
We looked at the distribution of variants in the core genome
of the population, using DK2 as a reference, as this strain
resulted in being the closest relative to this population (data
not shown). Data corresponding to insertions/deletions was
not considered as the draft nature of the genomes could bias
the output of the program. Each isolate contained a total
of 27,249 ± 3,300 single nucleotide variations. In particular,
variants per genome ranged from 12,983 to 29,744 in the isolates
TNCF_7M and TNCF_165, respectively, with a median number
of 28,668 nucleotide variations per genome (as in TNCF_23M
and TNCF_32) (Supplementary Table S2).
To investigate polymorphisms with a presumable impact
on the adaptive process of the isolates, we extracted non-
synonymous polymorphisms classified as high impact variants
(i.e., variants resulting in protein truncation, loss of function or
triggering non-sense-mediated decay). Considering the complete
genome sequence of the isolates (i.e., both core and accessory
genomes), the number of high impact variations considerably
varied in the population, ranging from six in the early isolate
TNCF_7M to 167 in the late isolate TNCF_175.
To determine whether the majority of variants fall into
few functional categories or are randomly distributed among
all of them, we performed a Cluster of Orthologous Groups
(COG) analysis, wherein we assigned the genes in which
high-impact variants were found to their respective COG
categories. The percentage of genes assigned to each COG
is shown in Supplementary Figure S7. Mutations occurred
primarily in genes involved in transcription (8%), followed by
amino acid transport and metabolism, inorganic ion transport
and metabolism, signal transduction mechanisms and general
functions (7% each). A large proportion of genes (28%) were
not assigned to any COG category but were classified as genes
with unknown function. The remaining mutated genes were
distributed into all functional groups, with proportions reflecting
those found in the analysis of whole genomes.
Polymorphisms in the Core Genome of
the Population
We then extended the analysis to variants in the core
genome with high and moderate impact (non-disruptive
variants that might change protein effectiveness). These ranged
from 132 (TNCF_7M) to 394 (TNCF_167, TNCF_175) per
genome, with a mean of 270 (Supplementary Table S2).
Moreover, an analysis of the distribution of variants in the
population (Supplementary Figure S8) revealed a cluster
of 13 isolates (TNCF_10, TNCF_13, TNCF_16, TNCF_23,
TNCF_23M, TNCF_32, TNCF_42, TNCF_42M, TNCF_49M,
TNCF_85, TNCF_88M, TNCF_101, TNCF_133_1) with a high
similarity in their variants pattern. One isolate, TNCF_7M,
stands out in the distance matrix, probably due to the lowest
number of SNPs present in the genome.
The analysis also highlighted the diverse subpopulations
putatively derived from the differentiation of a first infecting
strain, e.g., the isolates belonging to the ST1864 cluster, which
showed a marked similarity, with the only exception of the
isolated TNCF_151M, which was quite divergent compared to the
other strains.
Eight genes belonging to the core genome carried high-impact
variants. Interestingly, four of them have unknown function.
The gene encoding respiratory nitrate reductase subunit gamma
nail carried high impact variants in three closely related isolates,
one early, TNCF_14, and two lates, TNCF_130 and TNCF_151.
Isolates TNCF_133 and TNCF_167_1 had high impact variants
of two genes encoding a polyprotein signal peptidase lspA and a
hypothetical protein, and two hypothetical proteins, respectively.
Other genes with high-impact variants were those encoding the
ABC transporter-binding protein aaltP in TNCF_3, the copper
resistance protein A precursor pcoA in TNCF_175 and a gene
with unknown function in TNCF_174.
Within the whole population, a total of 675 different genes
carried mutations with moderate impact within the core genome
and the distribution of these variants was consistent with
population structure (Supplementary Figure S8). Focusing on
the moderate impact polymorphisms in the core genome, we
found 20 genes with three or more of such variations in the
population (Supplementary Table S3), which might be indicative
of loci under selective pressure (Table 2). Remarkably, 8 of them
were genes with a putative or unknown function. The pyoverdine
biosynthesis gene pvdL carried a total of five moderate-impact
SNPs in all 40 genomes analyzed, as well as the DNA gyrase
subunit B gyrB with five variants in 36 genomes. Remarkably
two amino acid substitutions, E468-D and S749-P, were found
in isolates resistant to fluoroquinolones. The topoisomerase IV
subunit B parE gene showed three different variations within the
population, including R30-C and H59-R in the late MDR isolates.
The two-component regulator system signal sensor kinase pmrB
gene showed three different variations among the population;
glnE and rsme (yggJ) carried three different variants, while cbrA
and gltB, nagE, aruF and pilL had three moderate variants in five,
four, and three different genomes, respectively.
We found that at least three genes, gyrB, parE, and pmrB,
involved in the resistance to different classes of antibiotics
carried mutations potentially affecting the protein function
(Supplementary Table S2).
Among the 20 most variable genes (with at least three
variations within the population) selected for the analysis of
adaptive evolution, nine resulted in being under non-neutral
pressure (namely gyrB and parE, pilL, nagE, gltB, gidA, and three
genes encoding hypothetical proteins) (Table 2). For 10 of them,
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TABLE 2 | Core genes with the highest number of SNPs in the population.
Gene name Product name Variations (n.)
gyrB DNA gyrase subunit B 5
pvdL Non-ribosomal peptide synthase,
pyoverdine biosynthesis
5
15595766 ∗ Hypothetical protein 4
aruF Subunit I of arginine
N2-succinyltransferase = ornithine
N2-succinyltransferase
3
ftsJ Cell division protein FtsJ 3
chpA Component of chemotactic signal
transduction system
3
gidA Glucose-inhibited division protein A 3
glnE Glutamate-ammonia-ligase
adenylyltransferase
3
gltB Glutamate synthase subunit alpha 3
nagE N-Acetyl-D-glucosamine
phosphotransferase system
transporter
3
parE DNA topoisomerase IV subunit B 3
pmrB Two-component regulator system
signal sensor kinase PmrB
3
cbrA Two-component sensor CbrA 3
15595416 ∗ Probable aldehyde dehydrogenase 3
15595440 ∗ Probable transcriptional regulator 3
15596248 ∗ Probable transporter 3
15596746 ∗ Probable cation-transporting
P-type ATPase
3
15597654 ∗ Hypothetical protein 3
15599121 ∗ Probable major facilitator
superfamily (MFS) transporter
3
15597414 ∗ Hypothetical protein 3
The 20 genes listed above belong to the core genome and have at least three
different polymorphisms with a moderate impact on the encoded protein according
to Snippy analysis (Seemann). Genes under non-neutral pressure are in bold.
∗ Corresponding gene accession number in the reference strain PAO1, when the
gene name is not available.
the neutral (null) hypothesis could not be rejected. For one gene,
pvdL, it was not possible to perform the test, because its sequence
was incomplete, probably due to the draft nature of the genomes.
All genes for which the likelihood ratio test rejected the null
hypothesis had an omega (dN/dS)> 1, suggesting they are under
positive selection.
Phenotypic Analyses
The mucoid phenotype, a characteristic marker of adaptation
to the CF lung, was present in 12 strains (30%), mainly early
and intermediate isolates, while 17 isolates (42.5%) produced a
detectable amount of biofilm (Supplementary Table S4).
For the mucoid phenotype, there was a significant inverse
correlation (ρ = −0.407, p = 0.009) with the time of
isolation, whereas Spearman’s coefficient indicated no significant
correlation (ρ = 0.202, p = 0.211) between biofilm formation
and time of sampling. A significant correlation between alginate
production and biofilm formation was observed (Supplementary
Table S5).
Antibiotic Resistance Profiles
Antibiotic susceptibility tests were performed for all isolates of
the population (Figure 6). Twelve different antibiotics belonging
to nine classes were tested (see the section “Materials and
Methods”). All the isolates were susceptible to colistin, whereas
nearly all the early isolates were susceptible to almost all the
antibiotics tested. On the other hand, resistant and multidrug-
resistant (MDR) phenotypes dramatically increased over time in
the persistent population (Supplementary Figure S9).
The vast majority of the 17 strains isolated in 2007 and 2008
were susceptible to nearly all the antibiotics tested, in particular,
TNCF_4M was found susceptible to all the antibiotics, while
TNCF_7M, TNCF_10, TNCF_10M, and TNCF_42M had an
intermediate resistance profile only to cefepime. Four strains
were found to have an MDR phenotype: TNCF_3, TNCF_6,
TNCF_12, and TNCF_14 were resistant to all antibiotics tested
with the exception of colistin.
Among 23 strains isolated between 2010 and 2014, only two of
them, TNCF_88M and TNCF_151M, both belonging to ST1864,
did not show an MDR phenotype: TNCF_88M, isolated on
December 2010, was susceptible to eight antibiotics, with an
intermediate profile to cefepime and resistant to ciprofloxacin,
levofloxacin, fosfomycin, and piperacillin/tazobactam; whereas
TNCF_151M, isolated on May 2013, was found to be susceptible
to 10 antibiotics tested, with an intermediate profile to Cefepime
and resistant only to amikacin.
The exacerbation of patient’s lung conditions started
approximately at the time of predominance of MDR, and
biofilm-forming isolates (Supplementary Figures S1, S9;
Supplementary Table S4). In the latest stages of infection,
the selected antibiotic therapy consisted of a combination of
glycopeptides, aminoglycosides, and carbapenems.
As a mucoid phenotype and biofilm formation are often
associated with an increase of antibiotic resistance, Spearman’s
correlation coefficient was applied to calculate the correlation
between the three phenotypes (Supplementary Table S4).
MDR was negatively significantly correlated with mucoidy and
positively correlated with biofilm formation.
Genomic analyses of the population showed a correlation
between the evolution of antibiotic resistance profiles, MLST
sequence types, and phylogenetic relationships (Figure 6). We
further investigated the MDR isolates in comparison to the
susceptible ones, looking specifically at the coding sequences
of P. aeruginosa genes involved in antibiotic resistance and
susceptibility. As described above, non-synonymous mutations
were found in gyrB, parE and pmrB; additional variants present
in the MDR isolates compared to the susceptible ones were:
1C437 in the outer membrane porin gene oprD leading to a
frameshift mutation in nearly all MDR isolates, P51-S in MexG
and N170-S in the topoisomerase IV subunit A ParC (Table 3 and
Supplementary Table S6).
DISCUSSION
Pseudomonas aeruginosa undergoes a characteristic evolutionary
adaptation during chronic infection in the CF lung.
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FIGURE 6 | Rooted phylogeny of the P. aeruginosa population with antibiotic susceptibility profiles. Resistance and susceptibility were determined according to the
EUCAST clinical breakpoint tables. Resistant, intermediate and susceptible isolates are highlighted in red, yellow, and green, respectively. AMI, amikacin; GEN,
gentamicin; IPM, imipenem; MEM, meropenem; DOR, doripenem; CAZ, cefepime; FEP, ceftazidime; CIP, ciprofloxacin; LVX, levofloxacin; FOS, fosfomycin; CST,
colistin; TZP, piperacillin/tazobactam.
Previous genomic studies have revealed extensive strain
genetic variability within patients, and adaptation to the
CF lung environment is recognized to play a crucial role
in the diversification of P. aeruginosa (Winstanley et al.,
2016).
The occurrence of a dominant Sequence Type in the
population together with a small number of closely related
genotypes indicates that all isolates likely belong to the same
clonal lineage and possibly evolved from a single ancestral
colonizing strain. This is in contrast with what has been
previously reported in other studies, in which either different
lineages coexist within CF patients (Feliziani et al., 2014;
Caballero et al., 2015; Williams et al., 2015) or a first infecting
lineage is replaced by a new one (Rau et al., 2010; Bianconi
et al., 2015). In this patient, a single dominant clonal lineage
apparently persisted in the airways for at least 8 years, allowing
us to perform a detailed study of the microevolution and
adaptive process of the bacterium in the course of chronic
infection.
We report the presence of two main lineages in the
population, with one of them being the most prevalent in the
latest stage of infection (Figure 1). Remarkably, this cluster
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TABLE 3 | Variations in genes involved in antibiotic resistance.
Gene Nt mutation Variation Isolates
gyrB G1404-T E468-D TNCF_3, TNCF_6, TNCF_12,
TNCF_13, TNCF_14, TNCF_68,
TNCF_69, TNCF_76, TNCF_85,
TNCF_88M, TNCF_101, TNCF_105,
TNCF_106, TNCF_109, TNCF_130,
TNCF_133_1, TNCF_151, TNCF_155,
TNCF_165, TNCF_167, TNCF_167_1,
TNCF_174, TNCF_175, TNCF_176
T2245-C S749-P TNCF_10, TNCF_10M, TNCF_23,
TNCF_23M, TNCF_32, TNCF_32M,
TNCF_42, TNCF_42M, TNCF_49M
mexG C151-T P51-S TNCF_3, TNCF_12, TNCF_68,
TNCF_76, TNCF_85, TNCF_88M,
TNCF_105, TNCF_106, TNCF_109,
TNCF_130, TNCF_133, TNCF_151,
TNCF_155, TNCF_165, TNCF_167,
TNCF_167_1, TNCF_174, TNCF_175,
TNCF_176
oprD 1C437 frameshift TNCF_3, TNCF_6, TNCF_12,
TNCF_68, TNCF_69, TNCF_101,
TNCF_105, TNCF_106, TNCF_133,
TNCF_155, TNCF_165, TNCF_167,
TNCF_167_1, TNCF_174, TNCF_175,
TNCF_176
parC A509-G N170-S TNCF_3, TNCF_12, TNCF_14,
TNCF_68, TNCF_76, TNCF_101,
TNCF_105, TNCF_106, TNCF_109,
TNCF_130, TNCF_151, TNCF_155,
TNCF_165, TNCF_167, TNCF_167_1,
TNCF_174, TNCF_175, TNCF_176
parE T88-C R30-C TNCF_69, TNCF_105, TNCF_106,
TNCF_133, TNCF_155, TNCF_155_1,
TNCF_165, TNCF_167, TNCF_167_1,
TNCF_174, TNCF_175, TNCF_176
G176-A H59-R TNCF_69, TNCF_105, TNCF_106,
TNCF_133, TNCF_155, TNCF_155_1,
TNCF_165, TNCF_167, TNCF_167_1,
TNCF_174, TNCF_175, TNCF_176
Nt, nucleotidic.
comprised most multi-drug resistant isolates. Although most
of the P. aeruginosa infections have a clonal origin, persistent
infections are characterized by an adaptive radiation process
leading to a marked diversification of the bacterial clones
(Cullen and McClean, 2015). The adaptive process most likely
occurs independently in the different individuals of the bacterial
population, resulting in the occurrence of clonal subpopulations
within the same host (Breidenstein et al., 2011). We have
previously characterized genotypically and phenotypically an
extensive collection of P. aeruginosa clinical strains isolated from
chronic and acute infections (Ballarini et al., 2012). One acute
infection isolate (VrPa97), from a wound swab and isolated
at the hospital of Verona, Italy, was found to belong to the
same genotype (ST390) as that of the isolates analyzed in
the present work, thus supporting the idea that very closely
related strains can cause acute infections and evolve into highly
adapted phenotypes after selection and persistence in the CF lung
environment.
A number of comparative genomic studies of P. aeruginosa
have shown that most inter-strain diversity is due to the presence
of regions of genomic plasticity (RGPs) or GIs often acquired
by horizontal gene transfer (Mathee et al., 2008; Kung et al.,
2010; Pohl et al., 2014). Plasmid pKLC102 plus six GIs were
detected in the population. pKLC102 was previously found in
strains of very different origins; this highly motile integrative
and conjugative element is almost ubiquitous in P. aeruginosa
(Klockgether et al., 2007). It was found to coexist in both
episomal and chromosome-integrated forms in P. aeruginosa
clone C strains (Klockgether et al., 2004). Three GIs could not
be assigned to any previously characterized island, whereas the
other ones could be assigned to LESGI-1, PAGI-2, and LESGI-
3. LESGI-1 and LESGI-3 were first identified and characterized
in the epidemic P. aeruginosa strain LESB58 (Winstanley et al.,
2009). LESGI-1 contains phage- and transposon-related genes,
in addition to coding sequences showing similarity with proteins
of non-pseudomonad species (Winstanley et al., 2009). LESGI-3
island has a mosaic structure and presents a significant homology
to PAGI-2, PAGI-3, PAGI-5, and PAPI-1 (Winstanley et al.,
2009; Silby et al., 2011). To date, it was described as a unique
island of the LESB58 strain, since its particular structure was
not found in other strains (Fothergill et al., 2010; Jani et al.,
2016). However, even if three PCs showed high identity with
both LESGI-3 and PAGI-2, two additional ones with an exclusive
assignment to LESGI-3 were found in a different genomic region.
It is, therefore, more straightforward to assign the first genomic
region to PAGI-2 and the second genomic region, located about
1 Mb downstream, to LESGI-3, rather than speculating on a
duplication event of LESGI-3. PAGI-2 was initially described
in P. aeruginosa clone C isolates (Larbig et al., 2002). This
island is divided into two main phage modules, one coding for
chromosome-partitioning proteins (soj) and another containing
a bacteriophage P4-related integrase (Klockgether et al., 2007).
PAGI-2 is present in approximately 40% of P. aeruginosa strains
(Klockgether et al., 2007).
Annotation of SNPs across the sequenced genomes allowed
the identification of a number of moderate or high impact
mutations in coding sequences (Table 2). Mutations in virulence
genes, like pyoverdine biosynthesis gene pvdL and pilin
biosynthesis gene chpA (pilL), are known as hallmarks of
adaptation of P. aeruginosa strains to the CF airway environment
(Winstanley et al., 2016). Siderophore-mediated processes have
been linked with virulence regulation of P. aeruginosa and its
pathogenic potential (Lamont et al., 2002) and non-synonymous
mutations were found in pvdL in the evolutionary pathway
leading to a hypermutable CF DK2 clone (Marvig et al.,
2014). However, in a study conducted on 36 CF patients,
pyoverdine was undetectable in one-third of sputa positive
for P. aeruginosa (Martin et al., 2011). The non-synonymous
variations of pvdL found in the present study have not been
characterized to date, and thus their potential role in the
defect in the biosynthesis and functionality of the siderophore
system cannot be assessed yet. The presence of pili is necessary
for the initial colonization and the translocation of type III
exotoxins (Hogardt and Heesemann, 2013), but adapted and
late CF isolates accumulate mutations in genes associated with
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pili, and loss of motility is associated with a higher risk of
persistent infections (Bragonzi et al., 2009; Bianconi et al.,
2015).
Several mutations in genes associated with antibiotic
resistance were detected. The outer membrane protein
OprD is involved in the resistance against β-lactams and
carbapenems (Li et al., 2012). The protein contains 16 β-strands
connected by short loops, eight of which are external loops
(Huang et al., 1995). The deletion present in the MDR
isolates of the population disrupts the protein just before
the fourth loop, and it has been reported that the deletion
of loops 3 and 4 results in a non-stable expression of the
protein (Huang et al., 1995). In P. aeruginosa repression
or inactivation of OprD or a reduced protein expression
contribute to moderate resistance to imipenem (Quale et al.,
2006; Rodriguez-Martinez et al., 2009; Poole, 2011), and
carbapenem-resistant strains are often defective in expression
of OprD (Naenna et al., 2010). Moreover, P. aeruginosa PA14
mutants for oprD showed an enhanced fitness in a murine
model of mucosal colonization and dissemination (Skurnik et al.,
2013).
Several variations were found in the genes encoding DNA
gyrase subunit B (GyrB) and topoisomerase IV subunit B (ParE),
which are both significant contributors to the acquisition of
resistance to fluoroquinolones (Lee et al., 2005). Five different
variants were detected for gyrB in 36 genomes. In particular,
amino acid substitutions E468-D and S749-P were found in
isolates resistant to fluoroquinolones, whereas the gene encoding
ParE showed three different variations within the population,
including R30-C and H59-R in the late MDR isolates (Table 3).
According to the likelihood ratio test, the null hypothesis of
neutrality was rejected for both genes, suggesting that they are
under non-neutral selection in the population (Table 2). The
amino acid substitution E468-D in GyrB was reported to be
associated to a high level of resistance to ciprofloxacin in clinical
isolates (Lee et al., 2005; Caballero et al., 2015). This variation is
within the quinolone resistance-determining regions (QRDR) of
the protein, while the mutations in parE are outside the QRDR
domain. Nonetheless, non-synonymous variations in gyrB and
parE have a low frequency in clinical isolates, and they are
described to have only a complementary role in fluoroquinolone
resistance (Lee et al., 2005; Lister et al., 2009).
In a recent study (Bruchmann et al., 2013), most of the
P. aeruginosa clinical isolates analyzed carried mutations either in
gyrA or gyrB or in both gyrA and parC. Mutations in parC gene,
encoding topoisomerase IV subunit A, along with those described
above in gyrB, are known to confer resistance to fluoroquinolones
(Mouneimné et al., 1999; Lee et al., 2005), while clinical isolates
with mutations in the QRDR of gyrA and parC show high
levels of fluoroquinolone resistance (Lister et al., 2009). A well-
characterized double threonine-serine variation in gyrA and parC
genes responsible for high-level resistance to fluoroquinolones
(Agnello et al., 2016; Fuzi et al., 2017) was not found in the this
study. However, while gyrA carried a G75-A variation only in
the seven strains belonging to the ST1864, we identified a yet
uncharacterized N170-S substitution in parC, present only in the
MDR isolates, but this variation is outside the QRDR domain.
The pmrB gene encoding the two-component regulatory
system signal sensor kinase showed three different variants within
the population. PmrB is part of the two-component regulatory
system PmrA/PmrB involved in resistance to polymyxins
and other cationic antimicrobial peptides in P. aeruginosa
(Moskowitz et al., 2004, 2012; Barrow and Kwon, 2009).
Considering that variations found in this population were not
directly associated with an MDR phenotype and that this gene
was not found to be under non-neutral selective pressure
(likelihood ratio test p-value > 0.05), we can assume that the
mutations are neutral.
MexG, a component of the eﬄux pump MexGHI-OpmD,
carries an amino acid substitution, P51-S, in nearly all the MDR
isolates; mutations in this pump are involved in the resistance
to tetracycline and ticarcillin-clavulanate and the export of non-
antibiotic compounds, including vanadium (Aendekerk et al.,
2002). However, the P51-S variant has not been reported to date.
Further investigations are thus needed to assess its putative role
in antibiotic resistance.
We observed a significant trend to lose the mucoid phenotype
over time in the population, and this phenotype did not correlate
with the antibiotic resistance profile of the isolates.
Pseudomonas aeruginosa is known to lose mucoid phenotypes
in the latest stages of CF lung disease, because the production
of alginate represents a high-energy cost for the bacterium
(Hogardt and Heesemann, 2010; Sousa and Pereira, 2014).
On another hand, conversion to a mucoid phenotype may
promote biofilm formation, which is a crucial factor for the
persistence of P. aeruginosa in CF airways (Sousa and Pereira,
2014) and a sessile lifestyle can efficaciously increase tolerance
and resistance to antibiotics (Häussler, 2010; Kostakioti et al.,
2013). Biofilm formation assay showed that the isolates grew
as sessile community mainly in the intermediate/late stage of
infection (Supplementary Table S4). These observations were
confirmed by Spearman’s correlation between phenotypes and
time. We checked if the differences observed in biofilm formation
could be due to mutations in the dual-regulator system PA1226–
PA1413 (Heacock-Kang et al., 2018), suppressing the ability of
P. aeruginosa to form biofilm in vitro. No difference in the two
genes between poor and good biofilm producers was found in this
study.
CONCLUSION
The analysis of the genomes of this longitudinal collection of
40 closely related P. aeruginosa strains belonging to the same
lineage and isolated from a single CF patient over a long-term
period provides new insights that increase our knowledge on the
adaptation and microevolution of this pathogen inside its human
host. The study revealed the emergence of a MDR phenotype over
time that could not be comprehensively explained by mutations
found in known resistance genes. Further investigations on
uncharacterized variations disclosed in this study should help
to increase our understanding of the development of MDR
phenotypes and the poor outcome of antibiotic therapies in many
CF patients.
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